Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study

Citation

Lidbury, B.A, Kita, B, Lewis, D et al 2017, 'Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study', Journal of Translational Medicine, vol. 15, no. 1.

Year

2017

ANU Authors

Fields of Research

  • Clinical Chemistry (Diagnostics)
  • Pathology (Excl. Oral Pathology)
  • Epidemiology

Updated:  28 October 2020 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers